Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.
Arend RC, Londoño-Joshi AI, Gangrade A, Katre AA, Kurpad C, Li Y, Samant RS, Li PK, Landen CN, Yang ES, Hidalgo B, Alvarez RD, Straughn JM, Forero A, Buchsbaum DJ.
Arend RC, et al. Among authors: yang es.
Oncotarget. 2016 Dec 27;7(52):86803-86815. doi: 10.18632/oncotarget.13466.
Oncotarget. 2016.
PMID: 27888804
Free PMC article.